Down regulation of BCL11B expression inhibits proliferation and induces apoptosis in malignant T cells by BCL11B-935-siRNA

Hematology

Volumn 16, Issue 4, 2011, Pages 236-242

  Huang, Xin ^a,b   Chen, Si ^a   Shen, Qi ^a   Chen, Shaohua ^a   Yang, Lijian ^a   Grabarczyk, Piotr ^c   Przybylski, Grzegorz K ^c,d   Schmidt, Christian A ^c   Li, Yangqiu ^a,e  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d INSTITUTE OF HUMAN GENETICS   (Poland)

^e JINAN UNIVERSITY   (China)

Author keywords

Apoptosis; BCL11B gene; Molt 4 cells9+; Nucleofection; Small interfering RNA; T ALL

Indexed keywords

SMALL INTERFERING RNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; BCL11B GENE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EXON; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LEUKEMIA CELL; MORPHOLOGY; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; RNA INTERFERENCE; T LYMPHOCYTE;

APOPTOSIS; CELL GROWTH PROCESSES; DOWN-REGULATION; GENE EXPRESSION; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOMA, T-CELL; REPRESSOR PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 79960125029     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453311X13025568941961     Document Type: Article

References (30)

1. Rivera GK, Crist WM. Acute lymphoblastic leukemia. In: Handin RI, Stossel TP, Lux SE, editors. Blood. Principles and practice of hematology. Philadelphia, PA: J. B. Lippincott Co.; 1995. p.743-59.
2. Uckun FM, Sensel MG, Sun L, Steinherz PG, Trigg ME, Heerema NA. Biology and treatment of childhood T-lineage acute lymphoblastic leukemia. Blood 1998;91:735-46.
3. Morris JC, Waldmann TA, Janik JE. Receptor-directed therapy of T-cell leukemias and lymphomas. J Immunotoxicol 2008;5:235-48.
4. Dearden CE, Matutes E, Cazin B, Tjønnfjord GE, Parreira A, Nomdedeu B, et al. High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. Blood 2001;98:1721-6.
5. Rodig SJ, Abramson JS, Pinkus GS, Treon SP, Dorfman DM, Dong HY, et al. Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H). Clin Cancer Res 2006;12:7174-9.
6. Ravandi F, O'Brien S. Alemtuzumab in CLL and other lymphoid neoplasms. Cancer Invest 2006, 24:718-25.
7. Ishida T, Ueda R. CCR4 as a novel molecular target for immunotherapy of cancer. Cancer Sci 2006;97:1139-46.
8. Peipp M, Küpers H, Saul D, Schlierf B, Greil J, Zunino SJ, et al. A recombinant CD7-specific single-chain immunotoxin is a potent inducer of apoptosis in acute leukemic T cells. Cancer Res 2002;62:2848-55.
9. Sato T, Yamochi T. CD26 regulates p38 mitogen-activated protein kinase-dependent phosphorylation of integrin beta, adhesion to extracellular matrix, and tumorigenicity of Tanaplastic large cell lymphoma Karpas 299. Cancer Res 2005;65:6950-6.
10. Steinbach D, Wittig S, Cario G, Viehmann S, Mueller A, Gruhn B, et al. The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype. Blood 2003;102:4493-8.
11. McKallip RJ, Lombard C, Fisher M, Martin BR, Ryu S, Grant S, et al. Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood 2002;100:627-34.
12. Villalba M, Altman A. Protein kinase C-theta (PKCtheta), a potential drug target for therapeutic intervention with human T cell leukemias. Curr Cancer Drug Targets 2002;2:125-37.
13. Elbashir S, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411:494-8.
14. Oh YK, Park TG. siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev 2009;61:850-62.
15. Devi RS. siRNA-based approaches in cancer therapy. Cancer Gene Ther 2006;13:819-29.
16. Whitehead KA, Langer R, Anderson DG. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 2009;8:129-38.
17. Cioca DP, Aoki Y, Kijosawa K. RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines. Cancer Gene Ther 2003;10:125-33.
18. Li L, Leid M, Rothenberg EV. An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b. Science 2010;329:89-93.
19. Wakabayashi Y, Watanabe H, Inoue J, Takeda N, Sakata J, Takeda N, et al. Bcl11bis required for differentiation and survival of ab T lymphocytes. Nat Immunol 2003;4:533-9.
20. zT lymphocytes. Blood 2006;108:2695-702.
21. Liu P, Li P, Burke S. Critical roles of Bcl11b in T-cell development and maintenance of T-cell identity. Immunol Rev 2010;238:138-49.
22. Przybylski GK, Dik WA, Wanzeck J, Grabarczyk P, Majunke S, Martin-Subero JI, et al. Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL. Leukemia 2005;19:201-8.
23. Karlsson A, Nordigården A, Jönsson JI, Söderkvist P. Bcl11bmutations identified in murine lymphomas increase the proliferation rate of hematopoietic progenitor cells. BMC Cancer 2007;7:195.
24. Su XY, Della-Valle V, Andre-Schmutz I, Lemercier C, Radford-Weiss I, Ballerini P, et al. HOX11L2/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32). Blood 2006;108:4198-201.
25. Oshiro A, Tagawa H, Ohshima K, Karube K, Uike N, Tashiro Y, et al. Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia/lymphoma. Blood 2006;107:4500-7.
26. Huang X, Chen S, Shen Q, Yang LJ, Li B, Zhong LY, et al. Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia. J Hematol Oncol 2010;3:44.
27. Grabarczyk P, Przybylski GK, Depke M, Völker U, Bahr J, Assmus K, et al. Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells. Oncogene 2007;26:3797-810.
28. Heidenreich O. Oncogene suppression by small interfering RNAs. Curr Pharm Biotechnol 2004;5:349-54.
29. 2zinc finger proteins implicated in transcriptional repression mediated by chicken ovalbumin upstream promoter transcription factor (COUP-TF) orphan nuclear receptors. J Biol Chem 2000;275:10315-22.
30. Onciu M, Lai R, Vega F, Bueso-Ramos C, Medeiros LJ. Precursor T-cell acute lymphoblastic leukemia in adults: agerelated immunophenotypic, cytogenetic, and molecular subsets. Am J Clin Pathol 2002;117:252-8.